Stockscreener 앱 받기
0.5783
3.29%
-0.0197
시장 영업 전:
.57
-0.0083
-1.44%
전일 마감가:
$0.598
열려 있는:
$0.6046
하루 거래량:
4.34M
Relative Volume:
0.84
시가총액:
$174.48M
수익:
$52.29M
순이익/손실:
$-134.84M
주가수익비율:
-0.7711
EPS:
-0.75
순현금흐름:
$-117.11M
1주 성능:
-8.08%
1개월 성능:
-15.32%
6개월 성능:
-20.60%
1년 성능:
-69.24%
1일 변동 폭
$0.5675
$0.6055
1주일 범위
$0.562
$0.6283
52주 변동 폭
$0.4111
$3.179
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
명칭
Sangamo Therapeutics Inc
전화
(510) 970-6000
주소
501 CANAL BLVD., RICHMOND, CA
SGMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGMO
Sangamo Therapeutics Inc
|
0.5783 | 180.42M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 업그레이드 | Truist | Hold → Buy |
| 2024-12-10 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-06-13 | 재개 | Wedbush | Neutral |
| 2021-05-04 | 개시 | RBC Capital Mkts | Outperform |
| 2021-01-07 | 재개 | Guggenheim | Neutral |
| 2021-01-06 | 개시 | Stifel | Hold |
| 2020-12-16 | 재개 | H.C. Wainwright | Buy |
| 2020-09-08 | 개시 | BofA Securities | Buy |
| 2020-07-07 | 개시 | SunTrust | Buy |
| 2019-08-26 | 개시 | H.C. Wainwright | Buy |
| 2018-11-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-06-20 | 개시 | BofA/Merrill | Buy |
| 2017-11-15 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2016-11-01 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-10-19 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | 개시 | Wells Fargo | Outperform |
| 2015-10-23 | 재개 | Jefferies | Buy |
| 2013-05-03 | 개시 | BioLogic Equity Research | Sell |
| 2011-02-23 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-07-29 | 재확인 | Wedbush | Outperform |
| 2009-10-19 | 개시 | Brean Murray | Sell |
| 2009-10-07 | 재확인 | Leerink Swann | Outperform |
| 2009-08-25 | 재확인 | JMP Securities | Mkt Outperform |
모두보기
Sangamo Therapeutics Inc 주식(SGMO)의 최신 뉴스
What analysts say about Sangamo Therapeutics Inc GBY stockMarket Entry Points & Free Extraordinary Earning Power - earlytimes.in
How buybacks impact Sangamo Therapeutics Inc. stock valuePortfolio Performance Summary & AI Forecasted Entry/Exit Points - newser.com
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call - Zenopa
Will Sangamo Therapeutics Inc. stock outperform Nasdaq indexWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Is Sangamo Therapeutics Inc. stock in correction or buying zoneJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Is Sangamo Therapeutics Inc. stock a safe haven asset2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Tick level data insight on Sangamo Therapeutics Inc. volatility2025 Major Catalysts & Fast Gain Stock Tips - newser.com
How Sangamo Therapeutics Inc. stock reacts to bond yieldsEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
Real time pattern detection on Sangamo Therapeutics Inc. stock2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Using AI based signals to follow Sangamo Therapeutics Inc.Weekly Stock Recap & Consistent Growth Equity Picks - newser.com
What analyst consensus says on Sangamo Therapeutics Inc. stock2025 Pullback Review & Verified Momentum Watchlists - newser.com
Detecting price anomalies in Sangamo Therapeutics Inc. with AIJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
What machine learning models say about Sangamo Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - newser.com
Sangamo Therapeutics Inc. stock chart pattern explainedMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
How hedge fund analytics apply to Sangamo Therapeutics Inc. stock2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Why retail investors favor Sangamo Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
What analysts say about Sangamo Therapeutics Inc stockEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in
Sangamo Therapeutics (NASDAQ: SGMO) to host earnings call Nov. 6 at 8:30 a.m. ET - Stock Titan
We're Hopeful That Sangamo Therapeutics (NASDAQ:SGMO) Will Use Its Cash Wisely - Yahoo Finance
Published on: 2025-10-29 21:25:18 - newser.com
Sangamo Biosciences Granted Nasdaq Compliance Extension - TipRanks
Sangamo Therapeutics Inc (SGMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):